Newsroom
Currently, Philip is Head of Discovery Research at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) in Hamburg, where he leads several activities in data-driven target validation and early drug discovery. He is involved in Fraunhofer’s programmes on targeted protein degradation and informatics initiatives for FAIR data and the application of machine learning methods to drug discovery and development (https://orcid.org/0000-0001-7655-2459).
In a 30-year professional career spent in academia, pharma, biotech, and not-for-profit research, Philip has contributed to academic and industrial programmes across many areas, from screening infrastructure technology development to drug discovery for rare diseases. EU-OPENSCREEN will benefit from his experience gained in the successful implementation of relevant EU and national projects, such as IDERHA, REMEDI4ALL, PROXIDRUGS, COMBINE, GNA-NOW, E4C, FAIRPLUS, EU-OS-DRIVE, EOSC-LIFE, EOSC-FUTURE, and ISIDORe. In addition to his day-to-day responsibilities, Philip also serves as vice president of the Society of Lab Automation and Screening (SLAS).
We believe Philip’s leadership will be instrumental in achieving EU-OPENSCREEN's mission and fostering collaborations within the life sciences community and beyond.